Healthly

Healthly

Blue Zones Health operates under the corporate vehicle Healthly, deploying a licensed consumer brand built on Dan Buettner's identification of five global longevity hotspots — Okinawa, Sardinia, Nicoya, Ikaria, and Loma Linda. The organization translates the Power 9® habits of those populations into reimbursable clinical encounters across Southern California, while developing a national telehealth platform. Board members Richard Barasch and Ben Leedle previously shaped Medicare Advantage and consumer-health enterprises, giving the entity a cohort of operators who understand value-based-care economics. The care model substitutes lifestyle intervention for prescription-first chronic-disease management. Patients receive nutritional counseling anchored to a whole-food, plant-based diet, natural-movement coaching, stress-management routines, and community-based walking groups called Moai. The practice reports that it reduces or eliminates medication dependency for some members and has captured patient-reported outcomes of reversed chronic-disease symptoms. Current in-person delivery is concentrated in Redlands, Banning, Culver City, Santa Monica, and Riverside, California, while the firm states that nationwide virtual care will launch through a dedicated platform accepting multiple insurance plans. The leadership team blends clinical MDs — Cono Badalamenti, Wayne Dysinger, and Dipika Pandit — with operational executives including Rachna Govani, Matthew Hellinger, and Brett McClung. Despite the licensed Blue Zones brand recognition, no public data exists on patient volume, total provider count, revenue, or external funding rounds. The corporate entity Healthly does not disclose a parent relationship to the Blue Zones LLC brand owner or to the original Blue Zones Project LLC that advises municipalities, leaving the precise licensing and ownership architecture opaque. This entity diverges from the franchise-based Blue Zones Project that certifies cities, and from the packaged-food licensing arm, by placing a provider group directly at the point of care. The structural question is whether Blue Zones Health intends to remain a regional medical group or scale into a multi-state risk-bearing provider — a pivot that would require regulated capital reserves and network-contracting depth. The board includes Brian Yoon, linking the firm to healthcare-growth capital circles, yet no disclosed transaction signals that structural shift has occurred.